ENDPQ — Endo International Share News
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
Brief: Endo And Premier Collaborate To Address Pitocin Shortage
Brief: Endo Launches First Generic Version Of Noxafil (Posaconazole) Injection
Brief: Endo Announces Approval Of XCOPRI In Canada
Brief: Endo Announces First Patient Enrolled In Registry Of Dupuytren's Contracture
Brief: Endo Announces Agreement With Slayback Pharma To Distribute Prevduo™
Brief: Endo Announces Launch Of Argatroban Injection Through Premier's Prorx® Private-Label Program
Brief: Endo International Launches Authorized Generic Version Of Noxafil® (Posaconazole) Oral Suspension
Factbox: US government to impose inflation penalties on 27 drugs
Brief: Endo Provides Top-Line Results From Phase 2 Study Of Collagenase Clostridium Histolyticum (Cch) In Participants With Plantar Fibromatosis
Novartis to pay $30 mln to health plans, consumers over Exforge antitrust claims
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics (updated)
Brief: Endo To Cease Production And Sale Of Qwo® (Collagenase Clostridium Histolyticum-Aaes)
Brief: Endo Reports Third-Quarter Results
CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims - sources (updated)
Brief: Endo International Received Nasdaq Letter Stating Co's Common Stock Will Be Delisted
U.S. STOCKS ON THE MOVE-Manchester United, Endo International, Blue Apron, Bed Bath & Beyond
Refinitiv Newscasts - Trading at Noon: Wall St falls as growth stocks slide, Target weighs on retail shares
U.S. STOCKS ON THE MOVE-Take-Two, RedHill Biopharma, Gold Miners,
U.S. STOCKS ON THE MOVE-Target, Bed Bath & Beyond, Hill International, Low's